Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lange

Showing results (561-570 of 1,082) with videos related to

Pageof 109
Sort By:
The Prostate|September 21, 2005
Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics ProjectSusan L Slager, Katherine E Zarfas, W Mark Brown, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxisJ Veenstra, P J Veugelers, I P Keet, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1989
Adjuvant chemotherapy (CMF) for stage III breast cancer: a randomized trialD P Derman, S Browde, I L Kessel, et al.
Digestive Surgery|April 26, 2005
The place of the posterior surgical approach for lesions of the rectumT Terkivatan, P T den Hoed, J F M Lange, et al.
Rapid Communications in Mass Spectrometry : RCM|May 5, 2012
Solvent-based and solvent-free characterization of low solubility and low molecular weight polyamides by mass spectrometry: a complementary approachCaroline Barrère, Marie Hubert-Roux, Catherine M Lange, et al.
Antiviral Therapy|March 7, 2002
Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experienceR P van Heeswijk, A Veldkamp, J W Mulder, et al.
The Journal of Infectious Diseases|September 1, 1993
Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudineM Koot, P T Schellekens, J W Mulder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCXE M Lange, H Chen, K Brierley, et al.
AIDS (London, England)|April 15, 1999
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patientsN A Foudraine, E Hovenkamp, D W Notermans, et al.
AIDS (London, England)|March 31, 1998
Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infectionL Van Damme, S Niruthisard, R Atisook, et al.
Pageof 109

Showing results (561-570 of 1,082) with videos related to

Sort By:
Pageof 109
The Prostate|September 21, 2005
Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics ProjectSusan L Slager, Katherine E Zarfas, W Mark Brown, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxisJ Veenstra, P J Veugelers, I P Keet, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1989
Adjuvant chemotherapy (CMF) for stage III breast cancer: a randomized trialD P Derman, S Browde, I L Kessel, et al.
Digestive Surgery|April 26, 2005
The place of the posterior surgical approach for lesions of the rectumT Terkivatan, P T den Hoed, J F M Lange, et al.
Rapid Communications in Mass Spectrometry : RCM|May 5, 2012
Solvent-based and solvent-free characterization of low solubility and low molecular weight polyamides by mass spectrometry: a complementary approachCaroline Barrère, Marie Hubert-Roux, Catherine M Lange, et al.
Antiviral Therapy|March 7, 2002
Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experienceR P van Heeswijk, A Veldkamp, J W Mulder, et al.
The Journal of Infectious Diseases|September 1, 1993
Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudineM Koot, P T Schellekens, J W Mulder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCXE M Lange, H Chen, K Brierley, et al.
AIDS (London, England)|April 15, 1999
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patientsN A Foudraine, E Hovenkamp, D W Notermans, et al.
AIDS (London, England)|March 31, 1998
Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infectionL Van Damme, S Niruthisard, R Atisook, et al.
Pageof 109